[December 28, 2020]
iBio Appoints Dr. Martin B. Brenner as Chief Scientific Officer
BRYAN, Texas, Dec. 28, 2020 (GLOBE NEWSWIRE) iBio, Inc. (NYSEA:IBIO) (âiBioâ or the âCompanyâ), a biotech innovator and biologics contract manufacturing organization, today announced the appointment of Martin B. Brenner, DVM, Ph.D., as its Chief Scientific Officer (âCSOâ), effective January 18, 2020.
âWe are thrilled to have Dr. Brenner join our team,â said Tom Isett, Chairman & CEO of iBio. âGiven his prior experience leading organizations with novel protein expression platforms to build proprietary product pipelines, Dr. Brenner should be uniquely suited to assist iBio with a similar transformation. Notably, he also brings a track-record of effective new target search and evaluation, as well as establishing productive collaborations.â
MODAG Initiates First-in-Patient Phase 1b Trial for Anle138b in Parkinson s Disease
MODAG, a German biotechnology company focused on the development of disease-modifying small molecule therapeutics for neurodegenerative diseases, today announced the clinical trial initiation of a first-in-patient Phase 1b study for anle138b in patients with mild to moderate Parkinson s Disease (PD). Anle138b is a disease-modifying treatment option for synucleinopathies, such as Multiple System Atrophy (MSA) and PD.
The short-term Phase 1b study with PD patients will be conducted by Quotient Sciences in Nottingham, UK, supported by the Neurology Department of Nottingham University Hospital. The study s primary endpoints include safety, tolerability and pharmacokinetics of anle138b in PD patients in order to establish the optimal dosing scheme for future long-term efficacy trials. The trial is supported by a grant of USD 1.4 million from The Michael J. Fox Foundation for Parkinson s Research.
Date Time
Aroma of Distant Worlds
Exotic Asian spices such as turmeric and fruits like the banana had already reached the Mediterranean more than 3000 years ago, much earlier than previously thought. A team of international researchers in Germany and the US has shown that even in the Bronze Age, long-distance trade in food was already connecting distant societies.
An international team at the Max Planck Institute for the Science of Human History in Jena, Ludwig Maximilian University of Munich, and Harvard University found evidence that exotic Asian spices such as turmeric and fruits like the banana reached the Mediterranean more than 3000 years ago, much earlier than previously thought.